ABBVIE BIOTHERAPEUTICS INC.;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
AFAR DANIEL,ANDERSON KENNETH C.,TAI YU-TZU,AFAR Daniel,ANDERSON Kenneth C.,TAI Yu-Tzu
申请号：
SI200731641
公开号：
SI2068874T1
申请日:
2007.08.07
申请国别(地区):
SI
年份:
2015
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
